Logo-apb
Adv Pharm Bull. 2018;8(2): 277-282. doi: 10.15171/apb.2018.032
PMID: 30023329        PMCID: PMC6046418

Research Article

PTPN22 Silencing in Human Acute T-Cell Leukemia Cell Line (Jurkat Cell) and its Effect on the Expression of miR-181a and miR-181b

Elham Baghbani 1, Vahid Khaze 1, Sanam Sadreddini 1, Ahad Mokhtarzadeh 1, Behzad Mansoori 1, Ali Mohammadi 1, Vida Vatankhahan 1, Parisa Toosi 1, Behzad Baradaran 1 *

Cited by CrossRef: 3


1- Kou Z, Mao M, Liu H, Wang X, Wang Z, Gu Z, Lang T, Nie Y, Wang Y, Huang Q, An L, Zhang X, Fu L, Li Y. CARD11 is a novel target of miR-181b that is upregulated in chronic lymphocytic leukemia. Biomarkers in Medicine. 2021;15(9):623 [Crossref]
2- Kakavandi S, Hajikhani B, Azizi P, Aziziyan F, Nabi-Afjadi M, Farani M, Zalpoor H, Azarian M, Saadi M, Gharesi-Fard B, Terpos E, Zare I, Motamedifar M. COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches. Cell Commun Signal. 2024;22(1) [Crossref]
3- Shen D, Hong Y, Feng Z, Chen X, Cai Y, Peng Q, Tu J. Development of dynamical network biomarkers for regulation in Epstein-Barr virus positive peripheral T cell lymphoma unspecified type. Front Genet. 2022;13 [Crossref]
4- Jadideslam G, Ansarin K, Sakhinia E, Babaloo Z, Abhari A, Ghahremanzadeh K, Khalili M, Radmehr R, Kabbazi A. Diagnostic biomarker and therapeutic target applications of miR‐326 in cancers: A systematic review. Journal Cellular Physiology. 2019;234(12):21560 [Crossref]